We hold that Tennessee Code Annotated section 39-17-1003 (2003) is not vague or overbroad in violation of the state or federal constitutions. We also hold that the charges against the defendant Pickett were multiplicitous and that the evidence supports only one conviction. Thus, we affirm the judgments of the Court of Criminal Appeals in each case.   IN THE SUPREME […]

At issue is the constitutionality of two statutory provisions enacted to protect minors from “indecent” and “patently offensive” communications on the Internet. Notwithstanding the legitimacy and importance of the congressional goal of protecting children from harmful materials, we agree with the three judge District Court that the statute abridges “the freedom of speech” protected by the First Amendment.

STATUTORY INSTRUMENTS 2019 No. 23 ELECTRONIC COMMUNICATIONS The Online Pornography (Commercial Basis) Regulations 2019 Made on 10th January 2019 Coming into force in accordance with regulation 1 The Secretary of State, in exercise of the powers conferred by section 14(2), (3) and (4) of the Digital Economy Act 2017(1), makes the following Regulations. A draft of these Regulations was laid before […]

A person contravenes this subsection if the person makes pornographic material available on the internet to persons in the United Kingdom on a commercial basis other than in a way that secures that, at any given time, the material is not normally accessible by persons under the age of 18.

The TAG-CO-VAC considers that COVID-19 vaccines that have high impact on prevention of infection and transmission, in addition to the prevention of severe disease and death, are needed and should be developed. Until such vaccines are available, and as the SARS-CoV-2 virus evolves, the composition of current COVID-19 vaccines may need to be updated, to ensure that COVID-19 vaccines continue to provide WHO-recommended levels of protection against infection and disease[4] by VOCs, including Omicron and future variants.

The Traditional Herbal Medicines Directive (Directive 2004/24/EC) was published on 30 April 2004. Products which were legally on the UK market on 30 April 2004 were not required to comply with the Directive until 30 April 2011. This meant that where an unlicensed herbal remedy sold under Section 12(2) of the Medicines Act had transitional protection, by April 2011 it must have had either a traditional herbal registration or a marketing authorisation or it must have been removed from the market. This transitional protection did not apply to any products placed on the UK market at any time from 30 April 2004 on wards.

Recent Updates